Champions Oncology Inc (CSBR) Return on Assets ROA from the first quarter of 2026 to first quarter of 2026 and for the year 2026, Average High and Low, Fundamental Ratios from Jul 31 2026 to Jul 31 2025 - CSIMarket
CSIMarket
 


Champions Oncology Inc   (NASDAQ: CSBR)


Champions Oncology Inc 's ROA from the first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Champions Oncology Inc 's ROA in the first quarter of 2026?
Champions Oncology Inc achieved a return on average assets (ROA) of 0.1 % in its first quarter of 2026, this is above CSBR's average return on assets of -41.23%.
Champions Oncology Inc assets over the 12 months ending in its first quarter of 2026 are valued at $38 million

Despite the company's net income deteriorating, Champions Oncology Inc was able to improve its ROA compared to the fourth quarter of 2026.

However, within the Healthcare sector 240 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2026 from 756 to 3613.

What is ROA?



Return On Assets (Jul 31 2026)
I. Quarter
(Apr 30 2026)
IV. Quarter
(Jan 31 2026)
III. Quarter
(Oct 31 2025)
II. Quarter
(Jul 31 2025)
I. Quarter
Y / Y Total Assets Change 47.75 % 32.68 % 23.77 % 19.5 % 23.81 %
Y / Y Net Income Change - - - -67.45 % -
Net Income (TTM) in million 0 0 -2 2 3
Return On Assets (TTM) 0.1 % -0 % -7.4 % 8.08 % 10.12 %
CSBR's Total Ranking # 3613 # 756 # 598 # 288 # 171
Total Assets (TTM) in million 45 45 32 30 30
Seq. Total Assets Change 0.07 % 38.54 % 7.23 % -0.62 % -10.14 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 27
Sector # 241
Overall # 2878

Return On Assets Statistics
High Average Low
25.1 %
-41.23 %
-175.77 %
(Jan 31 2025)   (Apr 30 2015)





Financial Statements
Champions Oncology Inc 's Assets $ 45 million CSBR's Balance sheet
Champions Oncology Inc 's Income $ 0 million Quarterly CSBR's Income Statement
CSBR's Income by Division See CSBR's Income by Division



Annual Return On Assets (Apr 30 2026)
FY 2026
(Apr 30 2025)
FY 2025
(Apr 30 2024)
FY 2024
(Apr 30 2023)
FY 2023
(Apr 30 2022)
FY 2022
Y / Y Total Assets Change 38.54 % 23.77 % -23.84 % -3.02 % 28.22 %
Total Assets in million 45 32 26 34 35
Y / Y Net Income Change - - - - 51.38 %
Net Income in million -1 5 -7 -5 1
Annual Return On Assets -2.62 % 14.53 % -27.84 % -15.55 % 1.55 %




More Return On Assets Ratios
CSBR's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CSBR's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CSBR's Competitors
Subscribers only: Roa for Champions Oncology Inc 's Suppliers
Subscribers only: Return On Assets for CSBR's Customers

You may also want to know
CSBR's Roi CSBR's Inventory Turnover Ratio CSBR's Growth Rates CSBR's Dividend Comparisons
CSBR's Profitability Ratios CSBR's Asset Turnover Ratio CSBR's Dividend Growth
CSBR's Roe CSBR's Valuation Ratios CSBR's Financial Strength Ratios CSBR's Dividend Payout Ratio



Companies with similar Return On Assets at Jul 31 2026, within Healthcare Sector ROA
Talkspace Inc   0.14 %
Champions Oncology Inc   0.13 %
Denali Therapeutics Inc   0.09 %


Date modified: 2026-09-13T23:25:19+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.